YungShin Global Holding Corporation (3705.TW)
TWD 66.9
(1.21%)
TWD 66.9
(1.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.35 Billion TWD | -16.99% |
| 2022 | 1.47 Billion TWD | 2.41% |
| 2021 | 1.43 Billion TWD | -2.47% |
| 2020 | 1.47 Billion TWD | -0.28% |
| 2019 | 1.37 Billion TWD | 9.37% |
| 2018 | 1.23 Billion TWD | 34.51% |
| 2017 | 922.09 Million TWD | -11.13% |
| 2016 | 1.03 Billion TWD | -22.2% |
| 2015 | 1.16 Billion TWD | 14.34% |
| 2014 | 1.13 Billion TWD | 10.69% |
| 2013 | 982.91 Million TWD | 29.77% |
| 2012 | 880.24 Million TWD | -16.49% |
| 2011 | 959.76 Million TWD | -3.54% |
| 2010 | 1.09 Billion TWD | 5.63% |
| 2009 | 1.03 Billion TWD | 322.31% |
| 2008 | 244.27 Million TWD | 0.0% |
| 2006 | 896.69 Million TWD | -17.04% |
| 2005 | 1.04 Billion TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 413.59 Million TWD | 16.83% |
| 2024 Q1 | 449.13 Million TWD | 0.11% |
| 2023 Q4 | 353.49 Million TWD | -17.39% |
| 2023 FY | - TWD | -16.99% |
| 2023 Q1 | 321.78 Million TWD | 59.53% |
| 2023 Q2 | 370.46 Million TWD | 15.13% |
| 2023 Q3 | 427.9 Million TWD | 15.5% |
| 2022 Q3 | 380.93 Million TWD | -22.76% |
| 2022 FY | - TWD | 2.41% |
| 2022 Q1 | 397.28 Million TWD | 6.24% |
| 2022 Q2 | 493.18 Million TWD | 24.14% |
| 2022 Q4 | 201.7 Million TWD | -47.05% |
| 2021 Q2 | 368.41 Million TWD | 11.43% |
| 2021 Q3 | 365.42 Million TWD | -0.81% |
| 2021 FY | - TWD | -2.47% |
| 2021 Q4 | 373.93 Million TWD | 2.33% |
| 2021 Q1 | 330.61 Million TWD | -4.0% |
| 2020 Q2 | 345.74 Million TWD | -19.06% |
| 2020 Q4 | 344.38 Million TWD | -3.68% |
| 2020 Q3 | 357.52 Million TWD | 3.41% |
| 2020 Q1 | 427.16 Million TWD | -5.39% |
| 2020 FY | - TWD | -0.28% |
| 2019 Q2 | 401.11 Million TWD | 21.99% |
| 2019 Q4 | 451.5 Million TWD | 51.77% |
| 2019 FY | - TWD | 9.37% |
| 2019 Q1 | 328.81 Million TWD | 2.32% |
| 2019 Q3 | 297.49 Million TWD | -25.83% |
| 2018 Q2 | 338.27 Million TWD | -0.51% |
| 2018 FY | - TWD | 34.51% |
| 2018 Q3 | 352.52 Million TWD | 4.21% |
| 2018 Q1 | 340.01 Million TWD | 50.09% |
| 2018 Q4 | 321.37 Million TWD | -8.84% |
| 2017 Q1 | 295.8 Million TWD | 36.08% |
| 2017 Q2 | 263.76 Million TWD | -10.83% |
| 2017 Q4 | 226.54 Million TWD | 3.36% |
| 2017 FY | - TWD | -11.13% |
| 2017 Q3 | 219.17 Million TWD | -16.9% |
| 2016 Q1 | 256.66 Million TWD | -43.77% |
| 2016 Q4 | 217.37 Million TWD | 4.96% |
| 2016 Q3 | 207.11 Million TWD | -54.03% |
| 2016 FY | - TWD | -22.2% |
| 2016 Q2 | 450.5 Million TWD | 75.53% |
| 2015 FY | - TWD | 14.34% |
| 2015 Q1 | 334.01 Million TWD | 13.19% |
| 2015 Q2 | 304.87 Million TWD | -8.72% |
| 2015 Q3 | 358.65 Million TWD | 17.64% |
| 2015 Q4 | 456.42 Million TWD | 27.26% |
| 2014 Q3 | 332.68 Million TWD | 2.39% |
| 2014 Q2 | 324.92 Million TWD | 1.88% |
| 2014 FY | - TWD | 10.69% |
| 2014 Q4 | 295.09 Million TWD | -11.3% |
| 2014 Q1 | 318.93 Million TWD | -5.68% |
| 2013 FY | - TWD | 29.77% |
| 2013 Q1 | 270.03 Million TWD | 37.61% |
| 2013 Q3 | 273.12 Million TWD | 2.09% |
| 2013 Q2 | 267.53 Million TWD | -0.92% |
| 2013 Q4 | 338.14 Million TWD | 23.81% |
| 2012 Q2 | 282.32 Million TWD | 20.5% |
| 2012 FY | - TWD | -16.49% |
| 2012 Q1 | 234.28 Million TWD | -12.67% |
| 2012 Q4 | 196.23 Million TWD | 19.61% |
| 2012 Q3 | 164.06 Million TWD | -41.89% |
| 2011 Q3 | 224.52 Million TWD | -45.55% |
| 2011 Q2 | 412.32 Million TWD | 170.79% |
| 2011 Q1 | 152.26 Million TWD | -86.14% |
| 2011 FY | - TWD | -3.54% |
| 2011 Q4 | 268.27 Million TWD | 19.48% |
| 2010 Q2 | - TWD | 0.0% |
| 2010 FY | - TWD | 5.63% |
| 2010 Q4 | 1.09 Billion TWD | 0.0% |
| 2010 Q1 | - TWD | 0.0% |
| 2010 Q3 | - TWD | 0.0% |
| 2009 FY | - TWD | 322.31% |
| 2008 FY | - TWD | 0.0% |
| 2006 FY | - TWD | -17.04% |
| 2005 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Grape King Bio Ltd | 2.88 Billion TWD | 52.951% |
| Standard Chem & Pharm CO., LTD. | 1.57 Billion TWD | 14.035% |
| Maywufa Company Ltd. | 239.81 Million TWD | -466.007% |
| ScinoPharm Taiwan, Ltd. | 819.15 Million TWD | -65.703% |
| Lotus Pharmaceutical Co., Ltd. | 6.87 Billion TWD | 80.245% |
| LIWANLI Innovation Co., Ltd. | 6.81 Million TWD | -19831.909% |
| PhytoHealth Corporation | -20.69 Million TWD | 6657.943% |
| SCI Pharmtech, Inc. | 529.61 Million TWD | -156.293% |
| Formosa Laboratories, Inc. | 1.16 Billion TWD | -16.682% |
| PharmaEssentia Corporation | -671.48 Million TWD | 302.143% |
| Bora Pharmaceuticals Co., LTD. | 5.73 Billion TWD | 76.329% |